CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***],
HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE
HARM TO THE COMPANY IF PUBLICLY DISCLOSED

 

FIFTH AMENDMENT TO DISTRIBUTION AGREEMENT

 

This Fifth Amendment to Distribution Agreement (the “Fifth Amendment”) is
effective as of December 12, 2019 (the “Fifth Amendment Effective Date”), by and
between Roche Diagnostics International AG, Basel Branch Diabetes Care, with
offices located at Peter Merian-Weg 4, 4052 Basel, Switzerland (“Roche
Diagnostics”) and Roche Diabetes Care GmbH, with offices located at Sandhofer
Strasse 116, 68305 Mannheim, Germany (“Roche Diabetes” and collectively with
Roche Diagnostics, “ROCHE”) and Senseonics, Incorporated, with offices located
at 20451 Seneca Meadows Parkway, Germantown, MD 20876-7005, USA (“SENSEONICS”). 
ROCHE and SENSEONICS are sometimes referred to herein individually as a “Party”
and collectively as the “Parties”.

 

WHEREAS, ROCHE and SENSEONICS are parties to that certain Distribution Agreement
dated May 23, 2016 (as amended, the “Agreement”), as amended from time to time
including the Amendments to Distribution Agreement dated as of November 28, 2016
(the “First Amendment”),  April 11, 2018 (the “Second Amendment”),  December 20,
2018 (the “Third Amendment”) and January 31, 2019 (the “Fourth Amendment”); and

 

WHEREAS, the Parties desire to amend the Agreement in accordance with Section
11.11 thereof in order to reduce the Minimum Requirement for 2020;

 

NOW THEREFORE, in consideration of the premises and mutual covenants contained
in the Fifth Amendment, the Parties agree as follows:

 

 

The Parties agree that the table shown on page 7 of the Fourth Amendment,
Exhibit 4 regarding the Minimum Requirement for 2019 – 2020 (units) shall be
amended as follows:

 

 

Minimum Requirement for 2019 – 2020 (units)

 

 

Eversense® XL Sensor Pack

Eversense® XL Smart Transmitter Pack

2019

[***]    

[***]

2020

[***]

[***]

 

Furthermore, the Parties would like to amend Section 1.c of the Fourth
Amendment, Exhibit 4 as follows:

 

1.c 2020 Pricing shall be [***] per Eversense XL Senor Pack.

 

 

 

[Remainder of Page Intentionally Blank]

 

 

 

IN WITNESS WHEREOF, each of the Parties has caused this Fifth Amendment to be
executed by its duly authorized representative as of the Fifth Amendment
Effective Date.

 

Senseonics, Incorporated  

 

By:  _____/s/ Tim Goodnow___________

 

Name:_____Tim Goodnow______________

 

Title:______President & CEO___________

 

Roche Diagnostics International AG

Basel Branch Diabetes Care

 

By:  ___/s/ Marcel Gmeunder ________

 

Name:___Marcel Gmeunder___________

 

Title:___CEO Diabetes Care___________

 

 

By:  ____/s/ Edwin Sonnenschein ______

 

Name:____Edwin Sonnenschein_________

 

Title:____Head Legal DC______________

 

Roche Diabetes Care GmbH

 

By:  ____/s/ Edwin Sonnenschein ______

 

Name:____Edwin Sonnenschein_________

 

Title:____Head Legal DC______________

 

 

By:  ____/s/ P. Hoffman______________

 

Name:_____ P. Hoffman _______________

 

Title:_____ Head Legal DC ____________

 

1